Article
Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein‐IgG Associated Disease Compared to Multiple Sclerosis
28 Feb 2025
Abstract excerpt
BACKGROUND: Little is known about cognitive outcomes in people with myelin oligodendrocyte glycoprotein-IgG associated disease (pwMOGAD). While there are similarities between MOGAD and multiple sclerosis (MS), further evaluation is needed to establish the distinct cognitive trajectories for each disease. METHODS: Retrospective review of subjective cognitive changes was performed for adult pwMOGAD. Subsets of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
